Forma, Oxford in deubiquitinating enzyme inhibitor deal

Forma Therapeutics Inc. (Watertown, Mass.) and University of Oxford (Oxford, U.K.) partnered to identify and develop deubiquitinating enzyme (DUB) inhibitors to treat neurodegenerative diseases. Form...